## Abstract The treatment of advanced stage thymomas and thymic carcinomas is a multimodal therapy. New therapeutic targets are currently under investigation, including the epidermal growth factor receptor (EGFR) as well as KIT. A number of studies have shown protumorigenic potential of Cyclooxygen
Steroid receptor expression in thymomas and thymic carcinomas
β Scribed by Takahiro Mimae; Koji Tsuta; Fumiaki Takahashi; Akihiko Yoshida; Tadashi Kondo; Yoshinori Murakami; Morihito Okada; Masahiro Takeuchi; Hisao Asamura; Hitoshi Tsuda
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 480 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Thymic malignancies are rare tumors. The insulinβlike growth factorβ1 (IGFβ1)/IGFβ1 receptor (IGFβ1R) system is involved in the development of the thymus. IGFβ1R expression in thymic epithelial malignancies is unknown. ## METHODS: The authors investigated the expressio
Ryanodine receptor (RyR) antibodies are present in sera of myasthenics with thymoma, and their titer correlates with morbidity and mortality. We investigated whether skeletal muscle RyR expression in thymic tissues could be the source of immune sensitization to the RyR. Skeletal muscle RyR gene expr
## Background: Sex steroid hormones influence function of the human gastrointestinal tract. although the specific receptor proteins have been identified in surgical specimens of both intestinal mucosa and colorectal carcinomas, it is still unknown whether they are expressed in intestinal epithelial